According to a market report by Lucintel, the future of the global women health disease diagnosis & treatment market looks promising with opportunities in the hospital, clinic, and diagnostic center markets. The global women health disease diagnosis & treatment market is expected to reach an estimated $28.8 billion by 2030 from $19.3 billion in 2024, at a CAGR of 6.5% from 2024 to 2030. The major drivers for this market are rising number of women health disorders, growing awareness concerning women healthcare, and increasing adoption of point-of-care and rapid diagnostic tests.
A more than 150-page report to understand trends, opportunity and forecast in women health disease diagnosis & treatment market to 2030 by type (urinary tract infection and condition, prenatal reproductive health, menopause, cancer, and osteoporosis), end use (hospitals, clinics, diagnostic centers, and others), and region (North America, Europe, Asia Pacific, and the Rest of the World).
Lucintel forecasts that cancer is expected to witness highest growth over the forecast period.
Within this market, hospitals will remain the largest segment.
Download sample by clicking on women health disease diagnosis & treatment market
APAC is expected to witness highest growth over the forecast period due to on-going improvement of healthcare infrastructure, growing awareness towards women health disorders, and rising adoption of POC diagnostics in the region.
General Electric, CooperSurgical, ASCEND Therapeutics, Rinovum WomenÄX%$%Xs Health, Quest Diagnostics Incorporated, Hologic, PerkinElmer, Cardinal Health, Becton and Dickinson, Abbott Laboratories are the major suppliers in the women health disease diagnosis & treatment market.
This unique research report will enable you to make confident business decisions in this globally competitive marketplace. For a detailed table of contents, contact Lucintel at +1-972-636-5056 or write us at [email protected] To get access of more than 1000 reports at fraction of cost visit Lucintel's Analytics Dashboard.
About Lucintel
At Lucintel, we offer solutions for you growth through game changer ideas and robust market & unmet needs analysis. We are based in Dallas, TX and have been a trusted advisor for 1,000+ clients for over 20 years. We are quoted in several publications like the Wall Street Journal, ZACKS, and the Financial Times.
Contact:
Roy Almaguer
Lucintel
Dallas, Texas, USA
Email: [email protected]
Tel. +1-972-636-5056
Explore Our Latest Publications
Nondestructive Testing Equipment Market
HVDC Capacitor Market
Image Sensor Market
Hot Melt Adhesives Market
Soft Wall Military Shelter Market
Superalloys In The Aerospace Market